Table II. The correlation of clinical factors and incidence of pulmonary metastases in 298 patients with surgically treated colorectal liver metastases.
Factors | Pulmonary recurrence |
||||
---|---|---|---|---|---|
Yes |
No |
||||
Clinical factors | n=127 | % | n=171 | % | p value |
Gender | 0.434 | ||||
Male | 70 | 55 | 102 | 60 | |
Female | 57 | 45 | 69 | 40 | |
Age (years) | 0.165 | ||||
< 60 | 63 | 50 | 71 | 42 | |
≤ 60 | 64 | 50 | 100 | 56 | |
UICC TNM staging | 0.305 | ||||
Stage I and II | 29 | 23 | 49 | 29 | |
Stage III | 44 | 35 | 48 | 28 | |
Stage IV | 44 | 35 | 53 | 31 | |
Unknown | 10 | 8 | 21 | 12 | |
Primary histological differentiation | 0.752 | ||||
Well/moderate | 89 | 70 | 121 | 71 | |
Poor | 13 | 10 | 21 | 12 | |
Unknown | 25 | 20 | 29 | 17 | |
Treatment time of liver metastases | 0.582 | ||||
Synchronous | 34 | 27 | 41 | 24 | |
Metachronous | 93 | 73 | 130 | 76 | |
No. of liver metastases | 0.300 | ||||
1 | 42 | 33 | 61 | 36 | 0.140* |
2–3 | 42 | 33 | 66 | 39 | |
> 3 | 43 | 34 | 44 | 25 | |
Largest size of liver metastases | 0.427 | ||||
1–3 cm | 53 | 42 | 80 | 47 | 0.656* |
4–6 cm | 43 | 33 | 46 | 27 | |
> 7 cm | 31 | 24 | 45 | 26 | |
Preoperative CEA level (ng/ml) | 0.081 | ||||
≤ 5.0 | 24 | 19 | 53 | 31 | |
5.01–100.0 | 62 | 49 | 78 | 46 | |
> 100.0 | 21 | 16 | 23 | 13 | |
Unknown | 20 | 16 | 17 | 10 | |
Postoperative CEA level (ng/ml) | 0.201 | ||||
≤ 5.0 | 95 | 75 | 130 | 76 | |
> 5.0 | 25 | 20 | 24 | 14 | |
Unknown | 7 | 5 | 17 | 10 | |
Operation type | 0.004 | ||||
Resection only | 56 | 44 | 104 | 61 | |
Cryotherapy±resection | 71 | 56 | 67 | 39 |
* Analysed using Wilcoxon rank test.